Assessment of Skeletal Tumor Load in Metastasized Castration-Resistant Prostate Cancer Patients: A Review of Available Methods and an Overview on Future Perspectives
Metastasized castration-resistant prostate cancer (mCRPC), is the most advanced form of prostate neoplasia, where massive spread to the skeletal tissue is frequent. Patients with this condition are benefiting from an increasing number of treatment options. However, assessing tumor response in patien...
Main Authors: | Francesco Fiz, Helmut Dittman, Cristina Campi, Silvia Morbelli, Cecilia Marini, Massimo Brignone, Matteo Bauckneht, Roberta Piva, Anna Maria Massone, Michele Piana, Gianmario Sambuceti, Christian la Fougère |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-07-01
|
Series: | Bioengineering |
Subjects: | |
Online Access: | http://www.mdpi.com/2306-5354/5/3/58 |
Similar Items
-
Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program
by: Axel Heidenreich, et al.
Published: (2019-01-01) -
Automated Definition of Skeletal Disease Burden in Metastatic Prostate Carcinoma: A 3D Analysis of SPECT/CT Images
by: Francesco Fiz, et al.
Published: (2019-06-01) -
Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resistant Prostate Cancer
by: Bram De Laere, et al.
Published: (2021-03-01) -
Whole-Body [<sup>18</sup>F]-Fluoride PET SUV Imaging to Monitor Response to Dasatinib Therapy in Castration-Resistant Prostate Cancer Bone Metastases: Secondary Results from ACRIN 6687
by: Mark Muzi, et al.
Published: (2021-04-01) -
Early prostate-specific antigen response post-abiraterone as predictor of overall survival in metastatic castrate-resistant prostate cancer
by: Joshua P. Schiff, et al.
Published: (2019-05-01)